Literature DB >> 14173

Mechanism for calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urate.

C Y Pak, O Waters, L Arnold, K Holt, C Cox, D Barilla.   

Abstract

Since monosodium urate (NaU) may play an important etiologic role in the formation of renal stones containing Ca in patients with hyperuricosuria, the current studies were undertaken to define some of the physiocochemical factors which determine the formation of NaU. In solutions containing Na, uric acid was rapidly transformed to NaU at pH greater than 6. The results indicated that NaU, and not uric acid, was the stable phase above this pH. A reliable and simple method for the calculation of the state of saturation of urine with respect to NaU was developed from the ratio of concentration products of Na and total dissolved urate (Upi) in the ambient fluid before and after incubation of urine with synthetic NaU. The concentration product ratio closely approximated the ratio of activity products of Na+ and acid urate ion. In contrast, the relative saturation ratio, or the ratio of activity product of original sample and the thermodynamic solubility product of NaU, often differed from the activity product ratio in the individual urine samples. With the concentration product rate, it was found in 45 urine samples that a critical determinant for the supersaturated state with respect to NaU was the high concentration of UT. At UT greater than 300 mg/liter, urine samples were invariably supersaturated with respect to NaU. These results suggest that the nidus of NaU could potentially form in the urine of patients with hyperuricosuria and Ca stones.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 14173      PMCID: PMC333378          DOI: 10.1172/JCI108656

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  9 in total

1.  Heterogeneous nucleation with urate, calcium phosphate and calcium oxalate.

Authors:  C Y Pak; Y Hayashi; L H Arnold
Journal:  Proc Soc Exp Biol Med       Date:  1976-10

2.  The enzymatic spectrophotometric method for determination of uric acid.

Authors:  L LIDDLE; J E SEEGMILLER; L LASTER
Journal:  J Lab Clin Med       Date:  1959-12

3.  Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate.

Authors:  C Y Pak; L H Arnold
Journal:  Proc Soc Exp Biol Med       Date:  1975-09

4.  Sodium urate accelerates precipitation of calcium oxalate in vitro.

Authors:  F L Coe; R L Lawton; R B Goldstein; V Tembe
Journal:  Proc Soc Exp Biol Med       Date:  1975-09

Review 5.  Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis.

Authors:  F L Coe; A G Kavalach
Journal:  N Engl J Med       Date:  1974-12-19       Impact factor: 91.245

6.  Allopurinol treatment of uric-acid disorders in calcium-stone formers.

Authors:  F L Coe; L Raisen
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

7.  Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers.

Authors:  W G Robertson; M Peacock; B E Nordin
Journal:  Clin Sci       Date:  1971-05       Impact factor: 6.124

8.  Physicochemical basis for formation of renal stones of calcium phosphate origin: calculation of the degree of saturation of urine with respect to brushite.

Authors:  C Y Pak
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

9.  Solubility of uric acid and monosodium urate.

Authors:  W R Wilcox; A Khalaf; A Weinberger; I Kippen; J R Klinenberg
Journal:  Med Biol Eng       Date:  1972-07
  9 in total
  17 in total

1.  Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.

Authors:  Shameez Allie-Hamdulay; Allen L Rodgers
Journal:  Urol Res       Date:  2005-05-04

Review 2.  Hyperuricosuric calcium urolithiasis.

Authors:  Orson W Moe; Li Hao Richie Xu
Journal:  J Nephrol       Date:  2018-01-24       Impact factor: 3.902

Review 3.  The crystallization of monosodium urate.

Authors:  Miguel A Martillo; Lama Nazzal; Daria B Crittenden
Journal:  Curr Rheumatol Rep       Date:  2014-02       Impact factor: 4.592

Review 4.  Nephrolithiasis in children.

Authors:  Mary Ann Cameron; Khashayar Sakhaee; Orson W Moe
Journal:  Pediatr Nephrol       Date:  2005-08-23       Impact factor: 3.714

5.  Clinical and metabolic evaluation of patients with history of renal calculi in Qazvin, Iran.

Authors:  Maliheh Charkhchian; Simin Samani; Ehsan Merat
Journal:  Ir J Med Sci       Date:  2014-06-13       Impact factor: 1.568

6.  Uric Acid Nephrolithiasis: A Systemic Metabolic Disorder.

Authors:  Michael R Wiederkehr; Orson W Moe
Journal:  Clin Rev Bone Miner Metab       Date:  2011-12

Review 7.  Recent advances in the pathophysiology of nephrolithiasis.

Authors:  Khashayar Sakhaee
Journal:  Kidney Int       Date:  2008-12-10       Impact factor: 10.612

8.  Mechanism of hypercalciuria in genetic hypercalciuric rats. Inherited defect in intestinal calcium transport.

Authors:  D A Bushinsky; M J Favus
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

9.  Urinary excretion of urate in patients with calcium oxalate stone disease.

Authors:  H G Tiselius; L Larsson
Journal:  Urol Res       Date:  1983

Review 10.  Nephrolithiasis related to inborn metabolic diseases.

Authors:  Pierre Cochat; Valérie Pichault; Justine Bacchetta; Laurence Dubourg; Jean-François Sabot; Christine Saban; Michel Daudon; Aurélia Liutkus
Journal:  Pediatr Nephrol       Date:  2009-01-21       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.